Advertising, Promotions, and Related First Amendment Concerns: Part 2 Exploring the Subtleties and Safe Zones of Off-Label Communications
Joel Kurtzberg
Partner
Cahill Gordon and Reindel LLP (New York, NY)
- Clarifying FDA’s current position on First Amendment and off-label promotion
- The 21st Century Cures Act
- FDAMA 114
- What to expect concerning proposed legislation, rules changes and Citizen Petitions
- Cases and controversies: state AG actions and private tort claims